Liling Mei
Impact in
- Pharmaceutical Science top 2%
- Advanced Drug Delivery Systems
- Advancements in Transdermal Drug Delivery
- Drug Solubulity and Delivery Systems
- Molecular Medicine top 10%
Papers in
-
- Advanced Drug Delivery Systems 4
- Drug Solubulity and Delivery Systems 2
-
- Nanoparticle-Based Drug Delivery 2
- Silk-based biomaterials and applications 1
- Co-authors
- Chuanbin Wu (14 shared papers)Xin Pan (14 shared papers)Ying Huang (11 shared papers)Jintian Chen (8 shared papers)Di Huang (2 shared papers)Ge Li (1 shared paper)Yixuan Dong (1 shared paper)Pin Dong (1 shared paper)
- Journals
- Drug Delivery (2 papers)Biomaterials Science (2 papers)Colloids and Surfaces B Biointerfaces (2 papers)Acta Biomaterialia (1 paper)European Journal of Pharmaceutics and Biopharmaceutics (1 paper)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Liling Mei
14 papers receiving 486 citations
Peers
Comparison fields: 5 of 82
- Pharmaceutical Science 197
- Molecular Medicine 45
- Biomaterials 114
- Periodontics 32
- Rehabilitation 31
Countries citing papers authored by Liling Mei
This map shows the geographic impact of Liling Mei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liling Mei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liling Mei more than expected).
Fields of papers citing papers by Liling Mei
This network shows the impact of papers produced by Liling Mei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liling Mei. The network helps show where Liling Mei may publish in the future.
Co-authors
The 25 scholars most cited alongside Liling Mei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 113 | |
| 2 | 2017 | 59 | |
| 3 | 2017 | 50 | |
| 4 | 2020 | 38 | |
| 5 | 2015 | 37 | |
| 6 | 2017 | 34 | |
| 7 | 2015 | 28 | |
| 8 | 2018 | 26 | |
| 9 | 2015 | 23 | |
| 10 | 2017 | 20 | |
| 11 | 2021 | 17 | |
| 12 | 2021 | 17 | |
| 13 | 2017 | 17 | |
| 14 | 2014 | 15 |
About Liling Mei
Liling Mei is a scholar working on Pharmaceutical Science, Biomaterials, Cell Biology, Molecular Biology and Rheumatology, having authored 14 papers that have together received 494 indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (4 papers), Proteoglycans and glycosaminoglycans research (3 papers), Osteoarthritis Treatment and Mechanisms (2 papers), Nanoparticle-Based Drug Delivery (2 papers), Drug Solubulity and Delivery Systems (2 papers), Dental Anxiety and Anesthesia Techniques (1 paper), Silk-based biomaterials and applications (1 paper) and Corneal Surgery and Treatments (1 paper). The work is most often cited by research in Pharmaceutical Science (197 citations), Molecular Medicine (45 citations), Biomaterials (114 citations), Periodontics (32 citations) and Rehabilitation (31 citations). Liling Mei has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Chuanbin Wu, Xin Pan, Ying Huang, Jintian Chen, Di Huang, Ge Li, Yixuan Dong, Pin Dong, Zhouhua Wang and Tingting Peng. Their work appears in journals such as Drug Delivery, Biomaterials Science, Colloids and Surfaces B Biointerfaces, Acta Biomaterialia and European Journal of Pharmaceutics and Biopharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.